SIF

Poster Session Abstracts
P-II - Pharmacoepidemiology; Clinical Trials; Experimental and Clinical Toxicology; Pharmacoeconomics and drug access to the market; Drug Information


MAGNESIUM FOR ANEURYSMAL SUBARACHNOID HAEMORRHAGE: QUANTIFYING EFFECT SIZE BY TRIAL SEQUENTIAL ANALYSIS
Rossi E., Benemei S., Messori A.
POTENTIALLY INAPPROPRIATE PRESCRIBING IN NURSING HOMES RESIDENTS IN TUSCANY
Lucenteforte E., Collini F., Pepe P., Maggini V., Pugi A., Lorini C., Zaffarana N., Bonaccorsi G., Di Bari M., Cavallini M., Mugelli A., Vannacci A.
COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: AN ITALIAN MULTICENTRIC SURVEY
Simeon V., De Feo V., Laurenti L., Coscia M., Cortelezzi A., Chiarenza A., Pozzato G., Vigliotti M., Nunziata G., Fragasso A., Villa M., Grossi A., Selleri C., Deaglio S., La Sala A., Del Poeta G., Musto P., D'Arena G.
UTILIZATION OF DISEASE MODIFYING AGENTS IN MULTIPLE SCLEROSIS: ANALYSIS FROM AN ITALIAN ADMINISTRATIVE DATABASE
Furneri G., Scalone L., Ciampichini R., Cortesi P., Fornari C., Madotto F., Chiodini V., Cesana G., Mantovani L.
CREATION OF A LIST OF MODIFIABLE AND CLINICALLY IMPORTANT DRUG-DRUG INTERACTIONS (DDIS) IN ELDERLY POLY-TREATED PATIENTS: THE EXPERIENCE OF THE EMILIA ROMAGNA REGION
Raschi E., Piccinni C., Signoretta V., Di Candia L., di Castri L., Ajolfi C., Ravaglia G., Pieraccini F., Benini A., Magnani M., De Ponti F., Poluzzi E.
PREVALENCE OF POTENTIAL DRUG-DRUG INTERACTIONS (DDIS) IN ELDERLY POLY-TREATED PATIENTS: RESULTS FROM DATA MINING OF PRESCRIPTION ADMINISTRATIVE ARCHIVES
Piccinni C., Raschi E., Bonezzi S., Lionello L., Delfino M., D'Orlando C., Pagano P., Radici S., Ferretti A., Negri G., De Ponti F., Poluzzi E.
EFFICACY AND TOLERABILITY OF A COMBINATION PRODUCT WITH L-TRYPTOPHAN, GRIFFONIA SIMPLICIFOLIA, VITAMIN PP AND VITAMIN B6 IN PEDIATRIC MIGRAINE PROPHYLAXIS: AN OPEN STUDY
Pizza V., Busillo V., Cassano D., Agresta A., Colucci D'Amato C., Capasso A.
EFFECT OF AN EDUCATIONAL PROGRAM IN PRIMARY CARE: THE CASE OF LIPID CONTROL IN CARDIO-CEREBROVASCULAR PREVENTION
Arcoraci V., Santoni L., Ferrara R., Furneri G., Cannata A., Moretti S., Di Luccio A., Tari D., Pagliaro C., Corrao S., Tari M.
USE OF DOPAMINE AGONIST DRUGS IN CLINICAL PRACTICE: A POPULATION-BASED STUDY IN THE YEARS 2004-2010
Starvaggi G., Ferrara R., Cannata A., Italiano D., Trifirò G., Pagliaro C., Lombardi I., Tari D., Tari M., Capuano A., Spina E., Arcoraci V., Ferrajolo C.
THE EFFECT OF ZONISAMIDE IN PROPHYLAXIS THERAPY IN EPISODIC AND CHRONIC CLUSTER HEADACHE
Pizza V., Busillo V., Capasso A.
MIGRAINE AND EPISTAXIS: CLINICAL AND THERAPEUTIC EVIDENCES
Pizza V., Volpe G., Agresta A., Busillo V., Capasso A.
ANTIDEPRESSANT USE IN ITALIAN ELDERLY PATIENTS: A NATIONWIDE POPULATION BASED-STUDY
Sultana J., Italiano D., Spina E., Cricelli C., Pecchioli S., Lapi F., Trifirò G.
USE OF ANTIBIOTICS AND RISK OF VENTRICULAR ARRHYTHMIA: A NESTED CASE-CONTROL MULTI-DATABASE STUDY IN 5 EUROPEAN COUNTRIES
Oteri A., de Ridder M., Pecchioli S., Bezemer I., Garbe E., Schink T., Poluzzi E., Frøslev T., Sturkenboom M., Trifirò G.
USE OF ANTIPSYCHOTICS AND RISK OF VENTRICULAR ARRHYTHMIA: A NESTED CASE-CONTROL MULTI-DATABASE STUDY IN 5 EUROPEAN COUNTRIES
Oteri A., de Ridder M., Pecchioli S., Bezemer I., Garbe E., Schink T., Poluzzi E., Pilgaard Ulrichsen S., Sturkenboom M., Trifirò G.
PATTERN OF ANTIMICROBIALS USE IN THE HOSPITALS OF EMILIA-ROMAGNA REGION
Buccellato E., Lategana R., Melis M., Biagi C., Motola D., Vaccheri A.
DO CLINICAL TRIALS TELL THE WHOLE STORY? STATINS AS A CASE IN POINT
Bolcato J., Piovesan C., Terrazzani G., Franchin G., Pirolo R., Giusti P., Chinellato A.
USE OF NEPHROTOXIC DRUGS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A POPULATION-BASED STUDY IN SOUTHERN ITALY
Ingrasciotta Y., Tari M., Trifirò G., Giorgianni F., Sultana J., Caputi A., Savica V., Arcoraci V., Santoro D., Nucita A.
THERAPEUTIC EFFECTIVENESS IN A DIABETIC POPULATION OF THE TREVISO LOCAL HEALTH AUTHORITY NO. 9: A RETROSPECTIVE OBSERVATIONAL STUDY.
Pirolo R., Bolcato J., Franchin G., Terrazzani G., Paccagnella A., Giusti P., Chinellato A.
ANTIEPILEPTIC DRUGS: PRESCRIBING PATTERN AND POTENTIAL DRUG-DRUG INTERACTION RISK IN GENERAL PRACTICE
Italiano D., Ferrara R., Cannata A., Trifirò G., Oteri A., Gagliostro M., Starvaggi G., Pagliaro C., Lombardi I., Tari D., Tari M., Capuano A., Spina E., Arcoraci V., Ferrajolo C.
CAN SELF BLOOD GLUCOSE MONITORING PREVENT HOSPITALIZATION FOR HYPOGLYCEMIC EVENTS? A RETROSPECTIVE OBSERVATIONAL STUDY ON DIABETIC PATIENTS TREATED WITH INSULIN OR SULFONYLUREAS IN THE TREVISO LOCAL HEALTH AUTHORITY NO.9
Pirolo R., Bolcato J., Franchin G., Terrazzani G., Giusti P., Chinellato A.
PHARMACOKINETIC PROFILE ASSESSMENT STUDIES IN MALE AND FEMALE HEALTHY VOLUNTEERS COMPARING TWO NEW OD ORAL FORMULATIONS OF BACILLUS CLAUSII ENTEROGERMINA (4 X109 SPORES ORAL SUSPENSION OR 6 X 109 SPORES POWDER FOR ORAL SUSPENSION) VS CURRENT FORMULATIONS
Riva L., Ziviani L., Rusticali G., Lepore M., Uboldi M., Michelagnoli S., Milleri S., Scatigna M.
COMPARISON BETWEEN OBSERVATIONAL, INTERVENTIONAL, AND MEDICAL DEVICES CLINICAL TRIALS: HOW A TECHNICAL AND SCIENTIFIC SECRETARIAT OF AN ETHICS COMMITTEE WORKS ON THEIR EVALUATION
Tamburella A., Cicerone M., Marchetti M., Navarra P.
POLYDEOXYRIBONUCLEOTIDE INCREASES HEALING RATE OF CHRONIC DIABETIC ULCERS: RESULTS FROM A MULTICENTER, DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMISED, CLINICAL TRIAL
Squadrito F., Bitto A., Arcoraci V., De Caridi G., Pallio G., Sterrantino C., Minutoli L., Altavilla D.
RECENT REQUESTS TO THE ETHIC COMMITTEE OF THE UNIVERSITY HOSPITAL OF BOLOGNA OF “COMPASSIONATE USE” CONCERNING FORTHCOMING DRUGS: A REAL UNDELAYABLE THERAPEUTIC NEED OR COMPANIES’ PRE-MARKETING PROMOTIONAL ACTIVITY?
Montanaro N., Chiabrando G., Proni S., Melis M., Motola D.
NATIONAL ANTIDOTES DATA-BASE IN ITALY - ‘LA BANCA DATI NAZIONALE DEGLI ANTIDOTI (BANDA)’
Mazzoleni M., Buscaglia E., Petrolini V., Vecchio S., Giampreti A., Lonati D., Leonardi M., Costanzo V., Maystrova O., Manzo L., Locatelli C.
ANTIDOTES SUPPLY IN EMERGENCY FROM PAVIA POISON CONTROL CENTRE
Buscaglia E., Mazzoleni M., Lonati D., Losurdo A., Vecchio S., Petrolini V., Giampreti A., Aloise M., Chiara F., Maystrova O., Flachi D., Manzo L., Locatelli C.
RAMAN SPECTROSCOPY ANALYSIS OF PRIMARY CULTURED NEURONS FROM EPILEPTIC RAT BRAIN
Russo E., Malara N., Candeloro P., Russo V., Aiello R., Citraro R., Trunzo V., Aprigliano S., Casale F., Difabrizio E., De Sarro G., Mollace V.
REDOX STATE SURVEILLANCE IN HUMAN FIBROBLAST CULTURES DERIVED FROM CIRCULATING PROGENITOR CELLS (CPCS)
Malara N., Trunzo V., Failla P., Casale F., Russo V., Musolino V., Di Fabrizio E., Mollace V.
MONITORING OF DRINKING WATER QUALITY AT FERRARA CITY: STUDY OF METABOLIC PERTURBATION IN CYPRINUS CARPIO
Vivarelli F., Canistro D., Sapone A., Paolini M.
THE MARINE TOXIN PALYTOXIN INDUCES NECROTIC DEATH IN HACAT CELLS THROUGH MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) OPENING
Pelin M., Sosa S., Pacor S., Tubaro A., Florio C.
IN VITRO EFFECTS OF PALYTOXIN AND 42-HYDROXY-PALYTOXIN ON SKELETAL MUSCLE CELLS
Sosa S., Del Favero G., Sbaizero O., Poli M., Lorenzon P., Tubaro A.
CYTOTOXICITY AND DETECTION OF NEW ANALOGUES OF PALYTOXIN
D'Orlando E., Pelin M., Ciminiello P., Dell'Aversano C., Forino M., Tartaglione L., Poli M., Sosa S., Tubaro A.
TOXICITY OF PALYTOXIN AFTER REPEATED ORAL EXPOSURE IN MICE
Sosa S., Del Favero G., Beltramo D., Testai E., Tubaro A.
HISTONE DEACETYLASE 4 PROMOTES UBIQUITIN-DEPENDENT PROTEOSOMAL DEGRADATION OF SP3 IN SH-SY5Y CELLS TREATED WITH DI(2-ETHYLHEXYL) PHTHALATE (DEHP), DETERMINING NEURONAL DEATH.
Formisano L., Guida N., Laudati G., Montuori P., Canzoniero L., Di Renzo G.
EFFECTS OF NON-DIOXIN-LIKE POLYCHLORINATED BIPHENYL CONGENERS (PCB 101, PCB 153 AND PCB 180) ALONE OR MIXED ON MATURE ADIPOCYTES 3T3L1: INDUCTION OF LEPTIN RESISTANCE
Ferrante M., Amero P., Santoro A., Monnolo A., Mattace Raso G., Simeoli R., Pirozzi C., Calignano A., Meli R.
PARAQUAT AND MANEB DIFFERENTLY AFFECT OPIOID RECEPTOR GENE EXPRESSION IN HUMAN NEUROBLASTOMA SH-SY5Y CELLS
Caputi F., Lattanzio F., Carretta D., Candeletti S., Romualdi P.
ABUSE OF TRAMADOL IN A BINGE PATTERN IN A YOUNG WOMAN
Ferrari A., Tiraferri I., Palazzoli F., Licata M.
CHARACTERIZATION OF PALYTOXIN INDUCED INFLAMMATION AT THE SKIN LEVEL: AN IN VITRO STUDY ON KERATINOCYTES AND IMMUNITY CELLS CO-CULTURES
Pelin M., Sosa S., Ponti C., Gibellini D., Florio C., Tubaro A.
IN VITRO EVALUATION OF THE TOXICOLOGICAL EFFECTS INDUCED BY FLY ASH PARTICLES IN HUMAN AIRWAY EPITHELIAL CELLS
Forgiarini A., Carrara M., Ceccato R.
DRUGS AND PREGNANCY: 5 YEAR EXPERIENCE AT THE TERATOLOGIC SERVICE OF THE AZIENDA OSPEDALIERO-UNIVERSITARIA OF UDINE
Vogrig E., Cojutti P., Della Martina M., Marchesoni D., Baraldo M.
USE OF HEALTH CARE ADMINISTRATIVE DATABASES TO ESTIMATE THE BURDEN OF DIABETES MELLITUS: A POPULATION-BASED STUDY
Scalone L., Mantovani L., Furneri G., Ciampichini R., Cortesi P., Beck-Peccoz P., Orsi E., Fornari C., Madotto F., Chiodini V., Cesana G.
DESIGN OF SPECIFIC TOOLS TO EVALUATE THE COST OF ILLNESS (COI) OF RHEUMATOID ARTHRITIS
Marongiu C., Francisco C., Milla P., Gallicchio M., Cattel L., Azzolini V.
USE OF HEALTH CARE ADMINISTRATIVE DATABASES TO ESTIMATE INCIDENCE OF FOOT COMPLICATIONS IN DIABETES PATIENTS
Scalone L., Furneri G., Ciampichini R., Cortesi P., Fornari C., Madotto F., Chiodini V., Mantovani L., Cesana G.
POTENTIAL COST-EFFECTIVENESS OF THERAPEUTIC DRUG MONITORING OF ANTIRETROVIRAL DRUGS IN THE ROUTINE CLINICAL MANAGEMENT OF HIV-INFECTED PATIENTS.
Perrone V., Cattaneo D., Radice S., Sangiorgi D., Pallone E., Degli Esposti L., Clementi E.
CLINICAL PHARMACIST IN RESIDENTIAL SOCIAL CARE FOR ELDERLY: A STUDY OF BUDGET IMPACT
Franchin G., Bolcato J., Pirolo R., De Cosmo P., Caparrotta L., Terrazzani G., Chinellato A.